Related Experiment Video
Updated: Jun 18, 2026

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
Comparison between obtained mydriasis in type 2 diabetics and non-diabetic patients
Jacqueline Coblentz1, Mário M S Motta, Bruno F Fernandes
1Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil. j_coblentz@yahoo.com
Background/Aims:
To evaluate and compare obtained mydriasis with phenylephrine 10% associated with tropicamide 1% in type 2 diabetics and non-diabetic patients.
Methods:
A total of 50 patients (100 eyes) scheduled for fundoscopy were dilated with phenylephrine 10% and yropicamide 1% (group 0: n = 20 type 2 diabetic patients, 40 eyes, and group 1: n = 30 non-diabetic patients, 60 eyes). Only one drop per eye of each drug was administered. In both groups, pupil diameter was measured after 40 minutes of eye drops instillation.
Results:
Both groups were similar regarding age (p = 0.06, Mann-Whitney test). Mean pupil diameter in group 0 was 8.57 and 8.73 in group 1. There was no statistic difference between both groups (p = 0.44). Pupil diameter was greater than 7 mm in all patients (100%).
Conclusion:
When an appropriate drug combination is used, diabetic patients can achieve mydriasis as satisfactory as non-diabetic patients, allowing adequate fundus examination and/or retinopathy treatment.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
